SecSonar.com

AtriCure, Inc. (ATRC)

AtriCure, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

AtriCure, Inc. (ATRC) is a Medical - Instruments & Supplies company based in US with a market capitalization of $1.4B. Revenue grew 14.9% year-over-year and the company generated $48.3M in free cash flow. This page tracks ATRC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 1.3K employees · IPO Aug 5, 2005

Valuation

Valuation & price

$28.12 · as of May 17, 2026 · -33.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.89

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$42.41$34.30$26.20Jul 25Dec 25Jul 26Jul 7, 25$31.54Jul 9, 25$31.92Jul 11, 25$30.72Jul 15, 25$30.54Jul 17, 25$29.75Jul 21, 25$29.24Jul 23, 25$30.82Jul 25, 25$31.50Jul 29, 25$31.73Jul 31, 25$35.10Aug 4, 25$36.35Aug 6, 25$36.52Aug 11, 25$35.49Aug 13, 25$36.70Aug 15, 25$35.45Aug 19, 25$35.84Aug 21, 25$35.73Aug 25, 25$37.84Aug 27, 25$37.30Aug 29, 25$36.99Sep 3, 25$34.77Sep 5, 25$35.38Sep 9, 25$36.11Sep 11, 25$37.56Sep 16, 25$35.96Sep 18, 25$36.66Sep 22, 25$37.52Sep 24, 25$36.09Sep 26, 25$35.20Sep 30, 25$35.25Oct 2, 25$34.29Oct 6, 25$34.73Oct 8, 25$35.08Oct 10, 25$36.18Oct 14, 25$35.39Oct 16, 25$37.24Oct 21, 25$37.00Oct 23, 25$37.39Oct 27, 25$36.47Oct 29, 25$35.44Oct 31, 25$34.55Nov 4, 25$32.75Nov 6, 25$31.50Nov 10, 25$31.99Nov 12, 25$33.06Nov 14, 25$32.90Nov 18, 25$33.16Nov 20, 25$33.25Nov 25, 25$38.48Nov 28, 25$36.12Dec 2, 25$35.31Dec 4, 25$39.25Dec 8, 25$38.94Dec 10, 25$41.18Dec 12, 25$42.38Dec 16, 25$41.08Dec 18, 25$40.40Dec 22, 25$41.65Dec 24, 25$40.55Dec 29, 25$40.42Jan 2, 26$39.27Jan 6, 26$41.44Jan 8, 26$42.41Jan 12, 26$37.64Jan 14, 26$37.37Jan 16, 26$39.06Jan 21, 26$39.27Jan 23, 26$39.07Jan 27, 26$38.41Jan 29, 26$36.95Feb 2, 26$36.82Feb 4, 26$36.80Feb 9, 26$36.92Feb 11, 26$32.90Feb 13, 26$32.65Feb 18, 26$32.26Feb 20, 26$32.58Feb 24, 26$31.14Feb 26, 26$31.64Mar 2, 26$30.93Mar 4, 26$30.99Mar 6, 26$30.02Mar 10, 26$29.18Mar 12, 26$29.54Mar 17, 26$29.58Mar 19, 26$29.03Mar 23, 26$29.78Mar 25, 26$29.53Mar 27, 26$28.88Mar 31, 26$28.53Apr 2, 26$29.07Apr 7, 26$28.89Apr 9, 26$28.05Apr 13, 26$28.66Apr 15, 26$29.37Apr 17, 26$29.72Apr 22, 26$27.63Apr 24, 26$29.28Apr 28, 26$28.48Apr 30, 26$28.11May 4, 26$28.78May 6, 26$28.01May 8, 26$26.28May 12, 26$26.69May 14, 26$28.15May 18, 26$28.48May 20, 26$29.00May 22, 26$28.29May 28, 26$28.09Jun 1, 26$26.48Jun 3, 26$26.20Jun 5, 26$27.10Jun 9, 26$27.30Jun 11, 26$28.41Jun 15, 26$27.98Jun 17, 26$27.12Jun 22, 26$28.44Jun 24, 26$28.28Jun 26, 26$30.18Jul 2, 26$31.79
$25.8652-week range$42.41
Loading valuation history…

Fundamentals

Key fundamentals

$1.4B

Market cap

14.9%

Revenue growth (YoY)

74.4%

Gross margin

$48.3M

Free cash flow (USD)

-$79.4M

Net debt

Net cash position

1.7%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$155.1MFY 2017$174.7MFY 2018$201.6MFY 2019$230.8MFY 2020$206.5MFY 2021$274.3MFY 2022$330.4MFY 2023$399.2MFY 2024$465.3MFY 2025$534.5M
$155.1M$534.5M

Free cash flow by year

2016 → 2025

FY 2016$-22.8MFY 2017$-15.3MFY 2018$-10.4MFY 2019$-28.0MFY 2020$-25.1MFY 2021$-23.5MFY 2022$-39.0MFY 2023$-37.5MFY 2024$-11.3MFY 2025$48.3M
-$22.8M$48.3M

Gross margin by year

2021 → 2025

FY 202175.0%FY 202274.4%FY 202375.2%FY 202474.7%FY 202574.4%
75.0%74.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventStock Incentive Plan AmendedMay 19, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing

Questions

Frequently asked questions

What is AtriCure, Inc.'s market cap?

AtriCure, Inc. (ATRC) has a market capitalization of $1.4B.

What is ATRC's P/E ratio?

A meaningful P/E ratio is not available for ATRC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ATRC's price-to-book (P/B) ratio?

ATRC trades at 2.89 times book value per share.

Are insiders buying ATRC stock?

SEC Form 4 filings show no open-market insider buys at AtriCure, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Instruments & Supplies

STAA

STAAR Surgical Company

$1.5B

NNNN

Anbio Biotechnology Class A Ordinary Shares

$1.5B

KMTS

Kestra Medical Technologies, Ltd.

$1.2B

PLSE

Pulse Biosciences, Inc.

$1.8B

AZTA

Azenta, Inc.

$1.1B

QDEL

QuidelOrtho Corporation

$893.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.